Crossmark

Peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE

Crossref DOI link: https://doi.org/10.1016/j.remnie.2021.11.001

Published Print: 2022-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Prado-Wohlwend, S.

Bernal-Vergara, J.C.

Utrera-Costero, A.

Cañón-Sánchez, J.R.

Agudelo-Cifuentes, M.

Bello-Arques, P.
License Information

Text and Data Mining valid from 2022-01-01
More Information

This article is maintained by: Elsevier

Article Title: Peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE

Journal Title: Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.remnie.2021.11.001

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.remn.2021.11.001

Content Type: article

Copyright: © 2021 Sociedad Española de Medicina Nuclear e Imagen Molecular. Published by Elsevier España, S.L.U. All rights reserved.